DISEASE INDICATIONS: Hypercholesterolemia
MANUFACTURER: Regeneron Pharmaceuticals, Inc.
USAGE: Intravenous
MEDICINE APPROVED BY:
Food and Drug Administration (FDA)
Evkeeza (evinacumab) is a fully human monoclonal antibody that binds to and inhibits angiopoietin-like 3 (ANGPTL3), a protein that plays a key role in lipid metabolism. It is the first FDA-approved treatment that binds to and blocks the function of ANGPTL3.
